Risk Mitigation Measures for Coronavirus Disease 2019

被引:0
作者
Lu, Yujia [1 ]
Zhou, Ruke [2 ]
Zhang, Heran [3 ]
机构
[1] Southwest Univ, Coll Westa, Chongqing, Peoples R China
[2] Wuhan Univ, Sch Hlth Sci, Wuhan, Hubei, Peoples R China
[3] China Pharmaceut Univ, Coll Life Sci & Technol, Nanjing, Jiangsu, Peoples R China
来源
2020 INTERNATIONAL CONFERENCE ON GREEN DEVELOPMENT AND ENVIRONMENTAL SCIENCE AND TECHNOLOGY | 2020年 / 615卷
关键词
SARS-COV-2; VACCINES;
D O I
10.1088/1755-1315/615/1/012014
中图分类号
S2 [农业工程];
学科分类号
0828 ;
摘要
Since December 2019, Coronavirus disease 2019 (COVID-19) broke out in China and soon spread worldwide. The once-in-a-century pandemic brought unexpected effect on both economy and health globally. Up to August 12, 2020, more than 20 million cases have been diagnosed across nearly 200 countries. In some countries such as the United States and India, confirmed cases are still increasing substantially. However, China, as the most severe one in the early stage of the outbreak, has curbed epidemic and saved lives rapidly. The intention of this review is to discuss effective risk mitigation measures, with the main focus on those applied in China, aiming to provide actionable and achievable guidance for the fight against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the world. We analyzed, evaluated and summarized the crucial strategies, including risk communication, quarantine and isolation, vaccine and antiviral administration. The above risk mitigation measures have proven to be effective in fighting against the epidemic in China. In light of specific conditions, we believe these effective risk mitigation measures can be well applied in other countries. In this paper, we will analyze the solution to control the worldwide pandemic and even the epidemic occurring in the future.
引用
收藏
页数:14
相关论文
共 35 条
[11]   Initial impacts of global risk mitigation measures taken during the combatting of the COVID-19 pandemic [J].
de Bruin, Yuri Bruinen ;
Lequarre, Anne-Sophie ;
McCourt, Josephine ;
Clevestig, Peter ;
Pigazzani, Filippo ;
Jeddi, Maryam Zare ;
Colosio, Claudio ;
Goulart, Margarida .
SAFETY SCIENCE, 2020, 128
[12]   Analyzing the epidemiological outbreak of COVID-19: A visual exploratory data analysis approach [J].
Dey, Samrat K. ;
Rahman, Md. Mahbubur ;
Siddiqi, Umme R. ;
Howlader, Arpita .
JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (06) :632-638
[13]   Novel Roles of Chloroquine and Hydroxychloroquine in Graves' Orbitopathy Therapy by Targeting Orbital Fibroblasts [J].
Guo, Yan ;
Li, Hai ;
Chen, Xueying ;
Yang, Huasheng ;
Guan, Hongyu ;
He, Xiaoying ;
Chen, Yuxin ;
Pokharel, Sunil ;
Xiao, Haipeng ;
Li, Yanbing .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (06) :1906-1917
[14]  
Henan government, PREVENTION CONTROL B
[15]  
Holmes D, 2005, COMMUN THEOR
[16]  
Holshue ML., 2020, NEW ENGL J MED, V382, P929, DOI DOI 10.1056/NEJMoa2001191
[17]   An mRNA Vaccine against SARS-CoV-2-Preliminary Report [J].
Jackson, L. A. ;
Anderson, E. J. ;
Rouphael, N. G. ;
Roberts, P. C. ;
Makhene, M. ;
Coler, R. N. ;
McCullough, M. P. ;
Chappell, J. D. ;
Denison, M. R. ;
Stevens, L. J. ;
Pruijssers, A. J. ;
McDermott, A. ;
Flach, B. ;
Doria-Rose, N. A. ;
Corbett, K. S. ;
Morabito, K. M. ;
O'Dell, S. ;
Schmidt, S. D. ;
Swanson, P. A. ;
Padilla, M. ;
Mascola, J. R. ;
Neuzil, K. M. ;
Bennett, H. ;
Sun, W. ;
Peters, E. ;
Makowski, M. ;
Albert, J. ;
Cross, K. ;
Buchanan, W. ;
Pikaart-Tautges, R. ;
Ledgerwood, J. E. ;
Graham, B. S. ;
Beigel, J. H. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (20) :1920-1931
[18]   A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan [J].
Lau, Eric H. Y. ;
Hsiung, C. Agnes ;
Cowling, Benjamin J. ;
Chen, Chang-Hsun ;
Ho, Lai-Ming ;
Tsang, Thomas ;
Chang, Chiu-Wen ;
Donnelly, Christl A. ;
Leung, Gabriel M. .
BMC INFECTIOUS DISEASES, 2010, 10
[19]  
Li C. Y., 2020, Chinese science, P001
[20]  
Li R. X., MED SOC, P1